This commentary responds to a case and examines pragmatic concerns about operating a busy outpatient practice in compliance with new laws that regulate opioid prescribing. Specifically, the article considers how regulati...
Content in this section will include AAPM advocacy efforts, legislative news, public statements, etc.
The Drug Enforcement Administration announced proposed regulations to improve DEA's ability to oversee the production of dangerous drugs at the height of the national opioid crisis. This proposed regulation would further...
AAPM participates in the Multisociety Pain Workgroup (MPW), a coalition of medical specialty societies, comprising physicians dedicated to pain management. This group convened to review and comment on the Colorado Board ...
The Drug Enforcement Administration urges its DEA-registered practitioners and members of the public to be cautious of telephone calls (from a Salt Lake City area code) from criminals posing as DEA or other law en...
The U.S. Department of Health and Human Services (HHS) published a new Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics . Individual patients, as well as t...
Today, the U.S. Department of Health and Human Services published a new Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics - PDF . Individual patients, as well as t...
The Evidence-based Practice Center (EPC) Program at the Agency for Healthcare Research and Quality (AHRQ) has posted the draft report for the systematic review on Noninvasive Nonpharmacological Treatments for Chronic Pai...
The American Medical Association (AMA) continues to express its concerns over Walmart's corporate prescription opioid restriction policy in its recent letter to Walmart's Chief Medical and Analytics Officer. The new policy limit opioid prescriptions to seven days or 50 morphine milligram equivalents (MME) has caused harm to patients with acute, palliative, cancer-related, chronic pain and other medical conditions requiring amounts or doses greater than the corporate policy. According to the AMA, "this policy has disrupted legitimate medical practices that receive form letters telling them their prescribing rights under state law will be superseded by a Walmart-created algorithm that deems a physician unfit to prescribe."
CDC Media Statement: CDC today announced the updated number of confirmed and probable cases of lung injury and deaths associated with e-cigarette product use, or vaping. Full story.
CMS has issued a Request for Information (RFI) required by the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act) asking for public comment on way...